Store
Single Cell Analysis in Next-Generation Sequencing (NGS) Markets, 2022-2027
Publication Date: May 5, 2022
Tags: Clinical Diagnostics, Genetic Diseases, Hematology, Infectious Disease Testing Instruments, Next-Generation Sequencing (NGS), Next-Generation Sequencing (NGS) Systems, Oncology and Cancer, Sequencing, Sequencing Technologies
Pages: 45
SKU: 22-020
Single Cell Analysis in Next-Generation Sequencing Markets (NGS): Market Size and Forecast, Segment Breakouts, Secondary Research, 2022-2027 delves into the rapidly growing market for single cell genomics products, including hardware, software, consumables, and services associated with sequencing and downstream analysis.
Report Highlights:
- Market Overview:
- Detailed analysis of the single cell genomics market, including market size, forecasts, and segment breakouts from 2022 to 2027.
- Coverage of historical data for 2021, providing a solid foundation for trend analysis and future projections.
- Key Market Trends:
- Increasing number of cells profiled.
- Emergence of multi-omics products.
- Advancements in spatial/in situ genomics and transcriptomics.
- Challenges in data analysis and the introduction of new software and IT solutions.
- Convergence of technological advances.
- Impact of litigation on market dynamics.
- Technological Advancements:
- Evolution from manual processes to automated technologies in single cell analysis.
- Significant developments in amplifying DNA or RNA from individual cells.
- Introduction of new products enabling the isolation and preparation of large numbers of individual cells in parallel.
- Routine study of large numbers of genes in tens or hundreds of thousands of individual cells.
Strategic Insights:
- Challenges and Strategies:
- In-depth discussion of the trends, challenges, and strategies shaping the single cell genomics market.
- Focus on how companies are addressing data analysis challenges and leveraging technological advancements.
- Competitive Landscape:
- Analysis of the competitive situation, including market share estimates and revenue growth for key players.
- Overview of deals and product developments in the single cell genomics market.
Table: Single Cell Genomics Revenue Forecast, Hardware vs. Consumables, 2021-2027 (in millions $)
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | CAGR |
| Consumables | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Instruments/hardware | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Total Revenues | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
- Table 1-1: Single Cell Genomics Revenue Forecast, Instruments/Hardware vs. Consumables, 2021-2022 ($M)
- Figure 1-1: Single Cell Genomics Market Share, Instruments/Hardware vs. Consumables, 2021-2022 (%)
Scope and Methodology
Chapter 2: Introduction
Introduction
Applications
Infectious Disease
Understanding Cancer with miRNAs
Atherosclerosis Research
Neurological
Market Trends
Increasing Numbers of Cells Analyzed
Significant Interest in Multi-omics
Spatial Transcriptomics, In Situ Techniques Gaining Traction
Data Analysis, Data Volumes, High Dimensionality Challenging
Convergence of Technological Advances
Litigation With Most Major Companies
Deals, Collaborations
- Table 2-1: Selected Collaborations and Deals
Chapter 3: Market Analysis
Revenues Forecast
- Table 3-1: Single Cell Genomics Shares, Hardware vs. Consumables, 2021-2027 (%)
- Table 3-2: Single Cell Genomics Revenue Forecast, Hardware vs. Consumables, 2021-2027 ($M)
- Table 3-3: Single Cell Genomics Revenue Growth Rates, Hardware vs. Consumables, 2021-2027 (%)
- Figure 3-1: Single Cell Genomics Market Revenues, Consumables and Instruments/Hardware, 2021-2027
Regional Shares
- Table 3-4: Single Cell Genomics Regional Shares, (North America, APAC, Europe, ROW), 2021
- Figure 3-2: Single Cell Genomics Regional Shares, (North America, APAC, Europe, ROW), 2021
Competitive Analysis
- Table 3-5: Companies’ Involvement in Single Cell Genomics Areas
Products
- Table 3-6: Selected Single Cell Genomics Products/ Technologies
- Table 3-7: Selected Single Cell Genomics Product Introductions
Chapter 4: Company Profiles
10x Genomics
Bio-Rad
Dolomite Bio
Fluidigm
Illumina
Mission Bio
Qiagen
Takara Bio
Related products
Cell and Gene Therapy Deals Analysis, 2021-2024
June 3, 2024
Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 offers a comprehensive look at the dynamic and rapidly evolving cell and gene therapy market. This report highlights the significant deal-making activities that have taken place from Q1 2021 to Q1 2024, providing valuable insights for companies and…
Price range: $6,300.00 through $9,450.00
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition
April 23, 2024
Explore the latest trends and forecasts in the point-of-care (POC) diagnostic tests market with Kalorama Information’s The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition. Discover the key growth areas and technological advancements shaping the future of POC diagnostics.
Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in…
Price range: $7,000.00 through $10,000.00
The World Market for Vaccines, 2024
February 22, 2024
Vaccines are a cornerstone of preventive medicine, offering long-term or permanent immunity against diseases. They have been instrumental in near-eliminating many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Kalorama Information’s latest report, The World Market for Vaccines, 2024, provides a comprehensive analysis of adult…
Price range: $5,000.00 through $7,875.00
